tiprankstipranks
Trending News
More News >
Advertisement

ROSC - ETF AI Analysis

Compare

Top Page

ROSC

Hartford Multifactor Small Cap ETF (ROSC)

Rating:70Outperform
Price Target:
ROSC, the Hartford Multifactor Small Cap ETF, has a solid overall rating driven by several strong small-cap holdings with healthy financial performance and supportive earnings commentary, such as Frequency Electronics and Dillard’s, which add stability through solid balance sheets and reasonable valuations. Other contributors like HNI, Argan, and REV Group support the rating with good earnings and strategic growth, though some positions with higher leverage, valuation concerns, or financial instability—such as PTC Therapeutics and Indivior—temper the fund’s appeal. The main risk factor is its focus on smaller companies, which can face more volatility and financial pressure than larger, more established firms.
Positive Factors
Broad Sector Diversification
The fund spreads its investments across many sectors, which can help reduce the impact if any one industry struggles.
Several Strong Top Holdings
A number of the largest positions, such as Amkor, Argan, and Dillard’s, have shown strong recent performance, supporting the ETF’s overall returns.
Solid Recent Performance Trend
The ETF has delivered steady gains over the past month and quarter, indicating positive recent momentum in its small-cap strategy.
Negative Factors
Higher Expense Ratio for a Small-Cap ETF
The fund’s expense ratio is on the higher side compared with many broad market ETFs, which slightly reduces net returns over time.
Concentrated U.S.-Only Exposure
With almost all assets invested in U.S. companies, the ETF offers little geographic diversification and is heavily tied to the U.S. economy.
Mixed Performance Among Top Holdings
Some key positions, including Macy’s, PTC Therapeutics, and Indivior, have shown weak recent performance, which can drag on the fund if this continues.

ROSC vs. SPDR S&P 500 ETF (SPY)

ROSC Summary

Hartford Multifactor Small Cap ETF (ROSC) tracks the Hartford Multifactor Small Cap Index and invests in many smaller U.S. companies across different industries, including health care, consumer, financials, and technology. It uses a rules-based approach to pick stocks, aiming for a mix of value, quality, and momentum. Well-known names in the fund include Macy’s and Dillard’s. Someone might invest in ROSC for growth potential and diversification, since small companies can grow faster than large ones. A key risk is that small-cap stocks can be more volatile and can go up and down more sharply than the overall market.
How much will it cost me?The Hartford Multifactor Small Cap ETF (ROSC) has an expense ratio of 0.34%, which means you’ll pay $3.40 per year for every $1,000 invested. This is slightly higher than average for ETFs because it uses an actively managed multifactor strategy to select stocks, aiming to enhance returns and reduce risk. It’s a good option if you’re looking for a strategic approach to small-cap investing.
What would affect this ETF?The Hartford Multifactor Small Cap ETF (ROSC) could benefit from economic growth and innovation in sectors like Health Care and Technology, which are significant parts of its portfolio. However, it may face challenges from rising interest rates or economic slowdowns, which can disproportionately impact small-cap companies and consumer-focused sectors like Consumer Cyclical. Additionally, changes in U.S. regulations or trade policies could affect the ETF's performance due to its focus on U.S. small-cap stocks.

ROSC Top 10 Holdings

ROSC is leaning into U.S. small caps with a balanced mix of retailers, industrials, and niche tech and health names, but a few stocks are clearly steering the ship. Amkor and Argan are doing the heavy lifting, with rising momentum that’s giving the fund a helpful tailwind, while Frequency Electronics and Garrett Motion are also pulling their weight with solid recent gains. On the flip side, Macy’s and PTC Therapeutics are losing steam, modestly dragging on results. Overall, performance is driven more by stock picking than any single sector bet.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
HNI1.38%$508.22K$3.42B-4.13%
74
Outperform
PTC Therapeutics1.36%$500.69K$6.06B64.62%
72
Outperform
Macy's1.29%$475.15K$5.32B28.50%
74
Outperform
Amkor1.23%$453.30K$11.95B96.38%
69
Neutral
Frequency Electronics1.20%$443.17K$514.11M214.28%
76
Outperform
Indivior1.14%$421.59K$4.42B197.31%
66
Neutral
Garrett Motion1.14%$419.97K$3.51B90.50%
71
Outperform
Argan1.08%$399.24K$4.82B153.74%
73
Outperform
Dillard's1.06%$388.86K$9.49B29.79%
76
Outperform
REV Group1.03%$380.51K$3.12B84.15%
74
Outperform

ROSC Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
47.58
Positive
100DMA
46.19
Positive
200DMA
43.66
Positive
Market Momentum
MACD
0.45
Positive
RSI
55.56
Neutral
STOCH
17.61
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ROSC, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 48.92, equal to the 50-day MA of 47.58, and equal to the 200-day MA of 43.66, indicating a bullish trend. The MACD of 0.45 indicates Positive momentum. The RSI at 55.56 is Neutral, neither overbought nor oversold. The STOCH value of 17.61 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ROSC.

ROSC Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$36.85M0.34%
$99.42M0.45%
$77.46M0.75%
$73.75M0.18%
$71.58M0.35%
$65.52M0.04%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ROSC
Hartford Multifactor Small Cap ETF
49.06
6.33
14.81%
FSML
Franklin Small Cap Enhanced ETF
AFSM
First Trust Active Factor Small Cap ETF
STXK
Strive 2000 ETF
FLQS
Franklin LibertyQ U.S. Small Cap Equity ETF
BKSE
BNY Mellon US Small Cap Core Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement